Latest Contribution


The MACRO Trial: defining best management of chronic rhinosinusitis

A major UK trial in The Lancet finds ESS provides greater symptom relief than long-term macrolides for adults with CRS, supporting earlier surgery and fewer antibiotics. The MACRO Programme was established in 2016 when the UK National Institute of Health...


Management of olfactory dysfunction

An evidence-based update on olfactory dysfunction: who to image, how to test and what works – OT, CRS surgery, biologics and PRP. Olfactory dysfunction (OD) is highly prevalent, affecting more than 20% of the adult population with a clear age-related...


What I look for at a conference (and why you should go to BACO 2023)

Professor Claire Hopkins has attended more than her fair share of international meetings, and she shares her top tips. COVID has changed the face of medical education forever – who would have thought only a few years ago that we...